Diseases, Conditions, Syndromes

New study offers insights on genetic indicators of COPD risk

Researchers have discovered that genetic variations in the anatomy of the lungs could serve as indicators to help identify people who have low, but stable, lung function early in life, and those who are particularly at risk ...

Medical research

Researchers discover why drug for severe COPD becomes less effective

Roflumilast, a drug recently approved in the United States to treat severe chronic obstructive pulmonary disease (COPD), increases the production of a protein that causes inflammation, which possibly results in patients developing ...

Diseases, Conditions, Syndromes

New proteins to clear the airways in cystic fibrosis and COPD

University of North Carolina scientists have uncovered a new strategy that may one day help people with cystic fibrosis and chronic obstructive pulmonary disorder better clear the thick and sticky mucus that clogs their lungs ...

Medications

EU approves Sanofi drug for chronic lung disease

The European Union has approved Sanofi and Regeneron's blockbuster drug Dupixent for the treatment of chronic obstructive pulmonary disease (COPD), the French pharmaceutical giant said on Wednesday.

Diseases, Conditions, Syndromes

Revealing the gut's crucial role in lung disease

Research led by the Centenary Institute, the University of Technology Sydney, and the Hunter Medical Research Institute suggests that the gut microbiome plays a pivotal role in the development of chronic obstructive pulmonary ...

page 3 from 40